Resveratrol and Ophthalmic Diseases

被引:132
|
作者
Abu-Amero, Khaled K. [1 ,2 ]
Kondkar, Altaf A. [2 ]
Chalam, Kakarla V. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA
[2] King Saud Univ, Coll Med, Dept Ophthalmol, Glaucoma Res Chair, Riyadh 11424, Saudi Arabia
关键词
age-related macular degeneration; cataract; diabetic retinopathy; eye; glaucoma; ocular disease; phytochemicals; PIGMENT EPITHELIAL-CELLS; INDUCED OXIDATIVE STRESS; FACTOR-KAPPA-B; TRANS-RESVERATROL; NITRIC-OXIDE; RED WINE; TISSUE DISTRIBUTION; IN-VITRO; CANCER; ACTIVATION;
D O I
10.3390/nu8040200
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Resveratrol, a naturally occurring plant polyphenol found in grapes, is the principal biologically active component in red wine. Clinical studies have shown that resveratrol due to its potent anti-oxidant and anti-inflammatory properties are cardio-protective, chemotherapeutic, neuroprotective, and display anti-aging effects. Oxidative stress and inflammation play a critical role in the initiation and progression of age-related ocular diseases (glaucoma, cataract, diabetic retinopathy and macular degeneration) that lead to progressive loss of vision and blindness. In vitro and in vivo (animal model) experimental studies performed so far have provided evidence for the biological effects of resveratrol on numerous pathways including oxidative stress, inflammation, mitochondrial dysfunction, apoptosis, pro-survival or angiogenesis that are implicated in the pathogenesis of these age-related ocular disorders. In this review, we provide a brief overview of current scientific literature on resveratrol, its plausible mechanism(s) of action, its potential use and current limitations as a nutritional therapeutic intervention in the eye and its related disorders.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Sulforaphane and ophthalmic diseases
    Zhang, Yichi
    Zhao, Xiaojing
    Liu, Yang
    Yang, Xiuxia
    FOOD SCIENCE & NUTRITION, 2024, 12 (08): : 5296 - 5311
  • [2] Resveratrol: A miraculous natural compound for diseases treatment
    Koushki, Mehdi
    Amiri-Dashatan, Nasrin
    Ahmadi, Nayebali
    Abbaszadeh, Hojjat-Allah
    Rezaei-Tavirani, Mostafa
    FOOD SCIENCE & NUTRITION, 2018, 6 (08): : 2473 - 2490
  • [3] The Role of Resveratrol in Eye Diseases-A Review of the Literature
    Bryl, Anna
    Falkowski, Mariusz
    Zorena, Katarzyna
    Mrugacz, Malgorzata
    NUTRIENTS, 2022, 14 (14)
  • [4] Pathogenetic role of magnesium deficiency in ophthalmic diseases
    Agarwal, Renu
    Iezhitsa, Igor
    Agarwal, Puneet
    BIOMETALS, 2014, 27 (01) : 5 - 18
  • [5] Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases
    Carrizzo, Albino
    Forte, Maurizio
    Damato, Antonio
    Trimarco, Valentina
    Salzano, Francesco
    Bartolo, Michelangelo
    Maciag, Anna
    Puca, Annibale A.
    Vecchione, Carmine
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 61 : 215 - 226
  • [6] New Highlights of Resveratrol: A Review of Properties against Ocular Diseases
    Delmas, Dominique
    Cornebise, Clarisse
    Courtaut, Flavie
    Xiao, Jianbo
    Aires, Virginie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 29
  • [7] Pathogenetic role of magnesium deficiency in ophthalmic diseases
    Renu Agarwal
    lgor Iezhitsa
    Puneet Agarwal
    BioMetals, 2014, 27 : 5 - 18
  • [8] Significance of Resveratrol in Clinical Management of Chronic Diseases
    Wahab, Awais
    Gao, Kuo
    Jia, Caixia
    Zhang, Feilong
    Tian, Guihua
    Murtaza, Ghulam
    Chen, Jianxin
    MOLECULES, 2017, 22 (08):
  • [9] Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
    Tome-Carneiro, Joao
    Larrosa, Mar
    Gonzalez-Sarrias, Antonio
    Tomas-Barberan, Francisco A.
    Teresa Garcia-Conesa, Maria
    Carlos Espin, Juan
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (34) : 6064 - 6093
  • [10] Resveratrol and the eye: activity and molecular mechanisms
    Bola, Christina
    Bartlett, Hannah
    Eperjesi, Frank
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (05) : 699 - 713